Yi Ban
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
-
- Chemotherapy-induced cardiotoxicity and mitigation
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 4
- Cancer Cells and Metastasis 4
-
- Cancer therapeutics and mechanisms 4
- DNA Repair Mechanisms 3
- Ubiquitin and proteasome pathways 2
- Co-authors
- Leroy F. Liu (4 shared papers)Yi Lisa Lyu (4 shared papers)Chao‐Po Lin (3 shared papers)Anna M. Azarova (1 shared paper)John E. Kerrigan (1 shared paper)Yuan‐Chin Tsai (1 shared paper)Dingcheng Gao (8 shared papers)Xiaojing Ma (5 shared papers)
- Journals
- Cancer Research (2 papers)eLife (2 papers)Journal of Biological Chemistry (2 papers)Advances in experimental medicine and biology (1 paper)Cancer Biology & Therapy (1 paper)
- Partner nations
- United StatesChinaIsrael
In The Last Decade
Yi Ban
22 papers receiving 1.3k citations
Yi Ban's Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 503
- Cardiology and Cardiovascular Medicine 350
- Immunology 202
- Toxicology 33
- Biophysics 50
Countries citing papers authored by Yi Ban
This map shows the geographic impact of Yi Ban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Ban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Ban more than expected).
Fields of papers citing papers by Yi Ban
This network shows the impact of papers produced by Yi Ban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Ban. The network helps show where Yi Ban may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Ban, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Topoisomerase IIβ–Mediated DNA Double-Strand Breaks: Implications in Doxorubicin Cardiotoxicity and Prevention by Dexrazoxane Hit paper breakdown → | 2007 | 501 |
| 2 | Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis Hit paper breakdown → | 2021 | 220 |
| 3 | 2017 | 128 | |
| 4 | 2008 | 98 | |
| 5 | 2009 | 63 | |
| 6 | 2018 | 48 | |
| 7 | 2007 | 48 | |
| 8 | 2016 | 47 | |
| 9 | 2001 | 45 | |
| 10 | 2021 | 32 | |
| 11 | 2024 | 24 | |
| 12 | 2013 | 23 | |
| 13 | 2018 | 22 | |
| 14 | 2018 | 16 | |
| 15 | 2017 | 11 | |
| 16 | 2020 | 11 | |
| 17 | 2024 | 6 | |
| 18 | 2023 | 5 | |
| 19 | 2019 | 3 | |
| 20 | 1990 | 1 |
About Yi Ban
Yi Ban is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Toxicology, having authored 22 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Cells and Metastasis (4 papers), Immune cells in cancer (4 papers), Cancer therapeutics and mechanisms (4 papers), DNA Repair Mechanisms (3 papers), Immunotherapy and Immune Responses (3 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Oncology (503 citations), Cardiology and Cardiovascular Medicine (350 citations), Immunology (202 citations), Toxicology (33 citations) and Biophysics (50 citations). Yi Ban has collaborated with scholars based in United States, China and Israel. Frequent co-authors include Leroy F. Liu, Yi Lisa Lyu, Chao‐Po Lin, Anna M. Azarova, John E. Kerrigan, Yuan‐Chin Tsai, Dingcheng Gao, Xiaojing Ma, Vivek Mittal and Sharrell B. Lee. Their work appears in journals such as Cancer Research, eLife, Journal of Biological Chemistry, Advances in experimental medicine and biology and Cancer Biology & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.